India's Dishman Carbogen up after clean chit from US FDA
** Shares of India's Dishman Carbogen Amcis DSHM.NS up
8.8% after rising as much as 9.2% earlier in the day
** U.S. Food and Drug Administration has completed
inspections at unit's Swiss sites; conclusions classified as "no
action indicated" - drugmaker
** Stock set for its third straight week of gains, if trends
hold
** YTD, DSHM has gained 6.2%
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis